AU2003259154B2 - Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor - Google Patents

Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor Download PDF

Info

Publication number
AU2003259154B2
AU2003259154B2 AU2003259154A AU2003259154A AU2003259154B2 AU 2003259154 B2 AU2003259154 B2 AU 2003259154B2 AU 2003259154 A AU2003259154 A AU 2003259154A AU 2003259154 A AU2003259154 A AU 2003259154A AU 2003259154 B2 AU2003259154 B2 AU 2003259154B2
Authority
AU
Australia
Prior art keywords
compound
formula
mixture
acid
accordance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003259154A
Other languages
English (en)
Other versions
AU2003259154C1 (en
AU2003259154A1 (en
Inventor
Michael E. Garst
George Sachs
Jai Moo Shin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Winston Pharmaceuticals LLC
US Department of Veterans Affairs VA
Original Assignee
University of California
Winston Pharmaceuticals LLC
US Department of Veterans Affairs VA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, Winston Pharmaceuticals LLC, US Department of Veterans Affairs VA filed Critical University of California
Publication of AU2003259154C1 publication Critical patent/AU2003259154C1/en
Publication of AU2003259154A1 publication Critical patent/AU2003259154A1/en
Assigned to WINSTON PHARMACEUTICALS, LLC, THE U.S. GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA reassignment WINSTON PHARMACEUTICALS, LLC Request for Assignment Assignors: GARST, MICHAEL E, SACHS, GEORGE, SHIN, JAI MOO
Application granted granted Critical
Publication of AU2003259154B2 publication Critical patent/AU2003259154B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
AU2003259154A 2002-07-19 2003-07-15 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor Ceased AU2003259154B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39745902P 2002-07-19 2002-07-19
US60/397,459 2002-07-19
PCT/US2003/022419 WO2004009583A2 (en) 2002-07-19 2003-07-15 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor

Publications (3)

Publication Number Publication Date
AU2003259154C1 AU2003259154C1 (en) 2004-02-09
AU2003259154A1 AU2003259154A1 (en) 2004-02-09
AU2003259154B2 true AU2003259154B2 (en) 2006-12-07

Family

ID=30771064

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003259154A Ceased AU2003259154B2 (en) 2002-07-19 2003-07-15 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor

Country Status (23)

Country Link
US (3) US6897227B2 (US06897227-20050524-C00066.png)
EP (1) EP1556371B1 (US06897227-20050524-C00066.png)
JP (1) JP4463103B2 (US06897227-20050524-C00066.png)
KR (2) KR100788778B1 (US06897227-20050524-C00066.png)
AT (1) ATE323695T1 (US06897227-20050524-C00066.png)
AU (1) AU2003259154B2 (US06897227-20050524-C00066.png)
BR (1) BR0312802A (US06897227-20050524-C00066.png)
CA (1) CA2492718C (US06897227-20050524-C00066.png)
CO (1) CO5690576A2 (US06897227-20050524-C00066.png)
DE (1) DE60304726T2 (US06897227-20050524-C00066.png)
DK (1) DK1556371T3 (US06897227-20050524-C00066.png)
ES (1) ES2263028T3 (US06897227-20050524-C00066.png)
HK (1) HK1079207A1 (US06897227-20050524-C00066.png)
IL (1) IL166371A0 (US06897227-20050524-C00066.png)
MX (1) MXPA05000657A (US06897227-20050524-C00066.png)
NO (1) NO20050801L (US06897227-20050524-C00066.png)
NZ (1) NZ538221A (US06897227-20050524-C00066.png)
PL (1) PL375255A1 (US06897227-20050524-C00066.png)
PT (1) PT1556371E (US06897227-20050524-C00066.png)
RU (1) RU2292342C2 (US06897227-20050524-C00066.png)
TW (1) TW200502231A (US06897227-20050524-C00066.png)
WO (1) WO2004009583A2 (US06897227-20050524-C00066.png)
ZA (1) ZA200501116B (US06897227-20050524-C00066.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
JP4634144B2 (ja) * 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
MXPA06000410A (es) * 2003-07-15 2006-03-17 Allergan Inc Procedimiento para preparar profarmacos isomericamente puros de inhibidores de la bomba de protones.
US20060241037A1 (en) * 2003-10-03 2006-10-26 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
BRPI0507837A (pt) * 2004-02-18 2007-07-10 Allergan Inc métodos e composições para a administração intravenosa de compostos relacionados a inibidores de bomba de prótons
JP2007523163A (ja) * 2004-02-18 2007-08-16 アラーガン、インコーポレイテッド プロトンポンプインヒビターのプロドラッグの投与のための方法および組成物
CA2559127A1 (en) * 2004-03-11 2005-09-29 Allergan, Inc. Methods and compositions for the treatment of conditions related to gastric acid secretion
WO2005105786A1 (en) 2004-04-28 2005-11-10 Hetero Drugs Limited A process for preparing pyridinylmethyl-1h- benzimidazole compounds in enantiomerically enriched form or as single enantiomers
WO2007073301A1 (en) * 2005-12-23 2007-06-28 Astrazeneca Ab Benzoimidazole derivatives as prodrugs of proton pump inhibitors
US20070265311A1 (en) * 2006-01-10 2007-11-15 Rubino Mark P Therapeutic Salt Compositions and Methods
NZ572007A (en) * 2006-05-09 2010-12-24 Astrazeneca Ab Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
US20070293543A1 (en) * 2006-06-19 2007-12-20 Edward Lee THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z
WO2008036211A1 (en) * 2006-09-19 2008-03-27 Alevium Pharmaceuticals, Inc. Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
US20100265240A1 (en) * 2007-10-05 2010-10-21 Lg Electronics Inc. Plasma display device
KR20090035195A (ko) * 2007-10-05 2009-04-09 엘지전자 주식회사 플라즈마 디스플레이 장치
KR100895333B1 (ko) * 2007-11-01 2009-05-07 엘지전자 주식회사 플라즈마 디스플레이 패널의 구동 방법 및 그를 이용한플라즈마 디스플레이 장치
US8927559B2 (en) 2010-10-11 2015-01-06 Merck Sharp & Dohme Corp. Quinazolinone-type compounds as CRTH2 antagonists
ES2635030T3 (es) 2010-12-23 2017-10-02 Merck Sharp & Dohme Corp. Quinoxalinas y aza-quinoxalinas como moduladores del receptor CRTH2
US9290453B2 (en) 2010-12-23 2016-03-22 Merck Sharp & Dohme Corp. Quinolines and aza-quinolines as CRTH2 receptor modulators
CA2973370A1 (en) * 2015-01-09 2016-07-14 The Regents Of The University Of California Compositions and methods for treating gastrointestinal infections
CN108997177A (zh) * 2018-09-04 2018-12-14 邵阳学院 一种微波促进n-苯磺酰基硝基苯胺类化合物合成的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859030A (en) * 1994-06-10 1999-01-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria
WO2000009494A1 (en) * 1998-08-12 2000-02-24 Triangle Pharmaceuticals, Inc. Method of manufacture of 1,3-oxathiolane nucleosides
WO2002030920A1 (fr) * 2000-10-12 2002-04-18 Takeda Chemical Industries, Ltd. Composes derives de benzimidazole, leur procede de production et leur utilisation
US6559167B1 (en) * 1998-08-10 2003-05-06 Regents Of The University Of California Prodrugs of proton pump inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US430042A (en) * 1890-06-10 Valve
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
IL76839A (en) 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
US4758597A (en) 1987-05-15 1988-07-19 University Patents, Inc. Carenadiol and derivatives
US4965269A (en) 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5045522A (en) 1990-03-27 1991-09-03 Phillips Petroleum Company Absorption composition comprising zinc titanate for removal of hydrogen sulfide from fluid streams
CA2083606C (en) 1990-06-20 2001-08-21 Arne Elof Brandstrom Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
US5708017A (en) 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
US6093734A (en) 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6599167B2 (en) 2000-09-27 2003-07-29 Glenn Waltz Game call holder and amplifying device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859030A (en) * 1994-06-10 1999-01-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria
US6559167B1 (en) * 1998-08-10 2003-05-06 Regents Of The University Of California Prodrugs of proton pump inhibitors
WO2000009494A1 (en) * 1998-08-12 2000-02-24 Triangle Pharmaceuticals, Inc. Method of manufacture of 1,3-oxathiolane nucleosides
WO2002030920A1 (fr) * 2000-10-12 2002-04-18 Takeda Chemical Industries, Ltd. Composes derives de benzimidazole, leur procede de production et leur utilisation

Also Published As

Publication number Publication date
JP4463103B2 (ja) 2010-05-12
KR100788778B1 (ko) 2007-12-27
EP1556371B1 (en) 2006-04-19
DK1556371T3 (da) 2006-08-21
PT1556371E (pt) 2006-09-29
WO2004009583A3 (en) 2004-03-18
RU2292342C2 (ru) 2007-01-27
PL375255A1 (en) 2005-11-28
US20050143423A1 (en) 2005-06-30
ZA200501116B (en) 2006-11-29
CO5690576A2 (es) 2006-10-31
CA2492718A1 (en) 2004-01-29
HK1079207A1 (en) 2006-03-31
IL166371A0 (en) 2006-01-16
NO20050801L (no) 2005-02-15
US20050182101A1 (en) 2005-08-18
ATE323695T1 (de) 2006-05-15
RU2005105564A (ru) 2005-10-10
NZ538221A (en) 2006-11-30
AU2003259154C1 (en) 2004-02-09
US20040102484A1 (en) 2004-05-27
TW200502231A (en) 2005-01-16
MXPA05000657A (es) 2005-08-19
JP2005536519A (ja) 2005-12-02
BR0312802A (pt) 2005-04-19
US6897227B2 (en) 2005-05-24
DE60304726D1 (de) 2006-05-24
KR20070005029A (ko) 2007-01-09
KR100822981B1 (ko) 2008-04-16
AU2003259154A1 (en) 2004-02-09
ES2263028T3 (es) 2006-12-01
KR20050047078A (ko) 2005-05-19
WO2004009583A2 (en) 2004-01-29
CA2492718C (en) 2010-12-21
DE60304726T2 (de) 2007-08-09
EP1556371A2 (en) 2005-07-27

Similar Documents

Publication Publication Date Title
AU2003259154B2 (en) Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor
AU752292B2 (en) Prodrugs of proton pump inhibitors
JP2544567B2 (ja) ピリジン誘導体及びそれを含有する潰瘍治療剤
US6093734A (en) Prodrugs of proton pump inhibitors
TWI410409B (zh) 同位素取代之潘托拉唑(pantoprazole)
TWI394750B (zh) 同位素取代之質子泵抑制劑
CA2575718C (en) Salts of benzimidazole derivative with amines and process for manufacturing the same
US7294716B2 (en) Process for preparing isomerically pure prodrugs of proton pump inhibitors
JPS62263177A (ja) ベンズイミダゾ−ル化合物
RU2035461C1 (ru) Производные пиридина
WO2001014366A1 (fr) Procede de preparation de derives optiquement actifs de sulfoxyde
JP3374314B2 (ja) 結晶の製造法
RU2232159C2 (ru) Производные бензимидазола и фармацевтические композиции, содержащие пролекарство ингибитора протонного насоса
AU5849900A (en) Benzimidazole compounds
CZ2001457A3 (cs) Proléčiva inhibitorů protonové pumpy
KR20020095479A (ko) 결정의 제조방법

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; THE U

Free format text: FORMER APPLICANT(S): SACHS, GEORGE; SHIN, JAI MOO; GARST, MICHAEL E

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 02 JAN 2007.

FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 02 JAN 2007

MK14 Patent ceased section 143(a) (annual fees not paid) or expired